Profile

Cover photo
666 followers|221,347 views
AboutPostsPhotosYouTube

Stream

Novo Nordisk

Shared publicly  - 
 
Visit 'Stories' to learn more about how we're driving change to defeat diabetes and other serious chronic conditions - from funding a future to help Vietnamese children suffering from a chronic disease to how Team Novo Nordisk are inspiring, educating and empowering people living with diabetes http://bit.ly/1T1sa7P
5
1
Svend Dahl Løndal's profile photo
 
Novo nordisk b aktien 
 ·  Translate
Add a comment...

Novo Nordisk

Shared publicly  - 
 
Read about our pledge to only use electricity from renewable sources at all our global production sites by 2020 http://bit.ly/1ji3yv1
1
Add a comment...

Novo Nordisk

Shared publicly  - 
 
Today is World Diabetes Day. 415 million people have diabetes worldwide and nearly half of those cases are undiagnosed. Take the type 2 risk assessment now https://lnkd.in/ecdYZ8g
3
1
Add a comment...

Novo Nordisk

Shared publicly  - 
 
World Diabetes Day is soon with us and we’re encouraging everyone to get screened and know their risk. We have lots going on all around the world, which you’ll see more of next week. But first, take a simple test, know your risk and find out what you can do to change it http://bit.ly/WDDKnowYourRisk
2
Add a comment...

Novo Nordisk

Shared publicly  - 
 
Novo Nordisk is ranked number three in the 2015 Science​ Top Employers Survey, which recognises companies harnessing innovation and creating workplaces that recruit the brightest scientific minds. Read more here http://bit.ly/1Mm05Tr
2
Add a comment...

Novo Nordisk

Shared publicly  - 
 
Giving birth can be risky. Giving birth with gestational diabetes can be even riskier. In Nicaragua, Population Services International and PASMO have teamed up to launch an integrated project that targets this global issue http://bit.ly/1hWZRKw
1
1
Add a comment...

Novo Nordisk

Shared publicly  - 
 
We're partnering up with IBM - our aim to improve the lives of people with diabetes by making the management of the condition more simple, effective and measurable http://bit.ly/1NecM6i
1
Add a comment...

Novo Nordisk

Shared publicly  - 
 
Ever wondered how insulin is made to treat people living with diabetes and other serious chronic conditions? Here's your answer in seven simple steps http://bit.ly/1PXVSwd
4
3
Maria Teresa Vallejo Salgado's profile photo
2 comments
 
Imposible comprarlo por costo quisiera ver si tienen algún apoyo 
 ·  Translate
Add a comment...

Novo Nordisk

Shared publicly  - 
 
Ahead of World Diabetes Day on Saturday, the latest diabetes global figures are out from International Diabetes Federation http://bit.ly/1MZ3dv5
2
Add a comment...

Novo Nordisk

Shared publicly  - 
 
We’re investing DKK 2.1 billion in a new insulin filling facility in Denmark, creating 450 new jobs. The facility will produce medicines for the treatment of diabetes and obesity http://bit.ly/NewFacility
2
Add a comment...

Novo Nordisk

Shared publicly  - 
 
There's just over a week to get your application in for the Spring 2016 Novo Nordisk Internship Programme. We have 125 internship positions to be filled. Apply here http://po.st/IS16NNCPFB
1
Add a comment...

Novo Nordisk

Shared publicly  - 
 
A smarter #recruitment initiative is helping us to save time, money... and trees! Learn more here http://bit.ly/1NgELnM #sustainability  
1
1
Add a comment...
Story
Tagline
Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care
Introduction

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: haemophilia, growth disorders and obesity. 

Headquartered in Denmark, Novo Nordisk employs approximately 39,000 people in 75 countries and markets its products in more than 180 countries. For more information, visit novonordisk.com, Facebook, Twitter, LinkedIn, YouTube


Disclaimer for the Novo Nordisk Google+ page

The Novo Nordisk Google+ page is not intended for discussions about products made by Novo Nordisk A/S including the reporting of side effects associated with the use of prescription drugs. Any questions or comments specific to products should be made to your healthcare professional. This also not the place to seek medical advice.

If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: http://novonordisk.com/about_us/global_offices/global_offices.asp

For other comments or feedback please contact us here: http://novonordisk.com/about_us/contact_us/contact_us.asp 

Content

The Novo Nordisk Google+ page is managed by Novo Nordisk Corporate Communications in Denmark, on behalf of colleagues across the organisation.

We reserve the right to remove comments or block users who violate the terms of use.

  • Information purposes 
    The content on Novo Nordisk Google+ page is presented solely for informational purposes. The site does not provide you with advice or recommendation of any kind and should not be relied on as the basis for any decision or action. You are advised to consult professional advisors in the appropriate field with respect to the applicability of any particular aspect of the contents. In particular, nothing being published on the Novo Nordisk Google+ page constitutes an invitation or offer to invest or deal in Novo Nordisk securities. Further, the Novo Nordisk Google+ page provides selected information of diseases and their treatment. Such information is not intended as medical advice. Such information is not a substitute for the advice of a health care professional. If you have or suspect having any health problems, you should consult your general practitioner or other qualified health provider. 

  • Information provided ''as is''
    The information on this site is provided "as is" and Novo Nordisk makes no representations or warranties, expressed or implied, including but not limited to the implied warranties of merchantability, fitness for a particular purpose or non-infringement. Novo Nordisk makes no representations or warranties of any kind as to the completeness, accuracy, timeliness, availability, functionality and compliance with applicable laws. By following the Novo Nordisk Google+ page you accept the risk that the information may be incomplete or inaccurate or may not meet your needs or requirements. 

  • Disclaimed liability
    Neither Novo Nordisk nor our content providers shall be liable for any damages or injury arising out of your access to, or inability to access, the Novo Nordisk Google+ page or from your reliance on any information provided herein. Novo Nordisk disclaims any and all liability for direct, indirect, incidental, consequential, punitive, and special or other damages, lost opportunities, lost profit or any other loss or damages of any kind. This limitation includes damages or any viruses, which may affect your computer equipment. 

  • Links to other sites
    Content on Novo Nordisk Google+ page contains links to other sites that are not owned or controlled by Novo Nordisk, please be aware that we are not responsible for or have control over the privacy policies of these sites. This privacy statement applies only to information gathered on this site. We strongly encourage you to read the privacy statements of every site you visit that gathers personally identifiable information.


Availability

We will update and monitor our Novo Nordisk Google+ page during Danish office hours (GMT+1), Monday to Friday. Novo Nordisk Google+ page may occasionally be unavailable and we accept no responsibility for lack of service due to Google+ downtime.

Response time: Within 48 hours on weekdays.


Comments

We welcome feedback and ideas from all our followers, and endeavour to join the conversation where possible. However, we are not able to reply individually to all the comments we recieve on Novo Nordisk Google+ page.

We will read all comments and ensure that any emerging themes or helpful suggestions are passed to the relevant people in the organisation.

*******************************

Kasper Kofod
Corporate Communications
Novo Nordisk

Contact Information
Contact info
Phone
+45 4444 8888
Email